AstraZeneca
AstraZeneca reviews diversity in trials to ensure drugs work for all
Firm aims to apply ‘equity lens’ across clinical tests to ensure diverse population groups take part
Julia Kollewe
25, May, 2022 @5:00 AM
AstraZeneca boss calls for UK to provide new Covid-19 medicine to the vulnerable
Pharmaceutical CEO says it’s ‘sad’ that UK has failed to order Evusheld for the immunosuppressed
Julia Kollewe
29, Apr, 2022 @2:27 PM
LV=’s on board with £511,000 bonus for boss despite shambles of failed sale
Mark Hartigan has been given £511,000 bonus for 2021 – a humbler CEO would have let the dust settle
Nils Pratley
29, Mar, 2022 @5:36 PM
Oxford Covid jab gears up for final act: saving the rest of the world
Exclusive: After mishaps and misinformation, jab will build ‘global wall of immunity’, says director of Oxford Vaccine Group
Andrew Gregory Health editor
20, Mar, 2022 @2:00 PM
Professor Sarah Gilbert on the legacy of lockdown: We must ensure we are better prepared for future outbreaks
The pandemic has taught us that viruses are not easy to identify – and can spread like wildfire
Prof Sarah Gilbert
18, Mar, 2022 @2:00 PM
AstraZeneca’s Evusheld Covid-prevention drug gets UK approval
Treatment aimed at people who cannot be vaccinated is boost to firm’s coronavirus portfolio
Julia Kollewe
17, Mar, 2022 @2:40 PM
GlaxoSmithKline says it will not start any new clinical trials in Russia
Pharma firm joins AstraZeneca and Pfizer in saying it will not enrol new patients into studies
Julia Kollewe
17, Mar, 2022 @12:28 PM
AstraZeneca forecasts higher 2022 sales after record revenues
Drugmaker’s total revenues increased by 41% last year with help from $4bn Covid jab income
Julia Kollewe
10, Feb, 2022 @1:30 PM
Novavax Covid vaccine: what is it and will it make a difference?
Australia’s government is hoping the protein-based vaccine – approved by the TGA – will sway the hesitant to get the jab
Donna Lu
21, Jan, 2022 @7:00 PM
Which philosophy helps us confront the crises that beset us... ‘we first’ or ‘me first’? | Will Hutton
Great institutions like the BBC and the NHS show that neither can work effectively alone
Will Hutton
26, Dec, 2021 @8:30 AM
Steps taken to target Omicron with AstraZeneca jab, scientist says
Sandy Douglas, from Oxford University, says updated vaccine could ‘respond to any new variant more rapidly’
Léonie Chao-Fong
21, Dec, 2021 @11:47 PM
UK biotech firm Aptamer to float valued at £80.7m
York-based company makes synthetic antibodies for pharmaceutical firms including AstraZeneca
Julia Kollewe
20, Dec, 2021 @7:00 AM
1 / 82 pages